About Us

Dr. Winson Cheung

Dr. Winson Cheung

Senior Medical Oncologist, Principal Director of O2 (Clinical and Data Lead)

Dr. Winson Y. Cheung, MD, MPH, is a senior medical oncologist and real-world data scientist with over 15 years of cancer research experience. He is currently a Full Professor in the Departments of Oncology, Medicine, and Community Health Sciences at the University of Calgary where he is also the Provincial Director and Chair of the Health Services Research and Real-World Evidence (RWE) Generation Program at Cancer Control Alberta. Dr. Cheung’s main research interest is health outcomes research and RWE generation across all cancer types, including solid tumors and hematologic malignancies. He has cultivated strong and effective partnerships with public and private sectors. He is the Principal Director of the Oncology Outcomes (O2) Program that focuses on enriching data sources and leveraging new technologies to facilitate “fit-for-purpose” cancer RWE generation. His track record consists of over 100 invited presentations and over 200 peer-reviewed scientific manuscripts in the RWE space. He acts as the chief sounding board for projects using cancer data and serves as the preferred point of first contact for oncology RWE queries in Alberta.

Dr. Darren Brenner

Dr. Darren Brenner

Cancer Epidemiologist, Associate Director of O2 (Data and Methods Lead)

Dr. Darren Brenner, PhD, is an epidemiologist with over 10 years of experience conducting observational research on chronic diseases, including cancer. He is sought after for his analytic expertise and has provided oversight to large, multi-center analysis of complex real-world data sets as well as numerous systematic literature reviews and meta-analyses in the field of oncology. As an Associate Professor in the Department of Oncology at the University of Calgary, his program of research is heavily focused on improving the use of “big data” and facilitating the integration of advanced precision analytics to more robustly examine cancer risks and outcomes. These areas are increasingly demanded by important stakeholders, such as administrators and payers.

Dr. Safiya Karim

Dr. Safiya Karim

Medical Oncologist, Assistant Director of O2 (Clinical Co-Lead)

Dr. Safiya Karim, MD, MSc, is a medical oncologist and RWE researcher who is currently a Clinical Assistant Professor in the Department of Oncology at the University of Calgary. Prior to her recruitment, she completed a successful health outcomes research fellowship under the mentorship of several prolific real-world data scientists at Queen’s University. She has been a key member of the Alberta Cancer Outcomes Research Network (ACORN) through which she has conducted and published a number of high profile RWE studies. Her past research is diverse and includes work that has examined treatment patterns and outcomes for different cancers. Her findings illustrate how RWE can be used to inform input parameters for economic models and potentially support access to and reimbursement of novel drugs.

Devon Boyne

Dr. Devon Boyne

Cancer Biostatistician, Assistant Director of O2 (Chief Analytics Lead)

Dr. Devon Boyne has significant expertise in novel statistical methods and advanced analytics. He is a quantitative methodologist with a focus on the emulation of target trials, the estimation of indirect treatment comparisons, and the development and validation of risk prediction models using RWE. He is also a co- developer of BUGSnet, which is an R statistical package aimed at facilitating the conduct and reporting of Bayesian network meta-analyses. His work has spanned a wide spectrum of clinical settings, with a major focus in medical oncology.

Ms. Christie Farrer

Ms. Christie Rogers (Farrer)

Research Program Manager, Primary Administrative Lead of O2

Ms. Christie Rogers is an experienced research program manager, and has led numerous cancer research programs and initiatives at the University of Calgary and Alberta Health Services. She has a clinical background in nursing and has worked in various administration and operations roles within oncology over the last six years. Christie oversees O2 operations, including project management, research facilitation (contracts, ethics, grant preparation, etc.) and human resources activities. Christie also holds a staff position with the Faculty of Nursing, University of Calgary as research program manager for the Cuthbert Lab, focusing on patient and family centered cancer survivorship research.

Ms. Abbey Poirier

Ms. Abbey Poirier

Project Manager

Ms. Abbey Poirier, MSc has extensive research experience, specifically in the areas of cancer epidemiology, risk and prevention. She has co-authored over 30 peer-reviewed publications on these topics. With additional training in project management, Abbey has overseen the development and execution of various research projects including evidence syntheses and systemic literature reviews with large, multidisciplinary teams.

Dr. Tamer Jarada

Dr. Tamer Jarada

Senior Research Associate

Dr. Tamer N. Jarada, Ph.D., is a Data Scientist with over 13 years of academic and professional experience. Dr. Jarada’s current research is focused on understanding and improving the quality of health systems and patient outcomes. Dr. Jarada earned his Ph.D. in Computer Science from the University of Calgary. In his Ph.D. research, he addressed the demand for integrating various biological and biomedical datasets for data-driven insights in the Computational Drug Repositioning field. Dr. Jarada’s primary work and research interests are Health Informatics & Analytics, Bioinformatics, Biomedicine, Computational Biology, Machine Learning, Network Analysis, Natural Language Processing, Big Data Analytics, and Data Visualization.

Dr. Dylan O’Sullivan

Dr. Dylan O’Sullivan

Postdoctoral Fellow

Dr. Dylan E. O’Sullivan, PhD, is a post-doctoral fellow in the Department of Oncology at the University of Calgary. He is the recipient of a Canadian Institutes of Health Research (CIHR) postdoctoral scholarship. He is a trained molecular epidemiologist with considerable experience in research across the entire cancer continuum (primary prevention, screening, and outcomes). His post-doctoral work is focused on using big data and advanced analytics to inform efforts aimed at reducing the incidence and improving outcomes of young-onset colorectal cancer (< 50 years of age). He is a strong methodologist with experience conducting meta-analyses, analyses of multi-center data, data reduction and clustering algorithms, prediction modelling, and causal inference analytics.

Mr. Liam Sutherland

Mr. Liam Sutherland

PhD Student

Mr. Liam Sutherland has a background in cancer biology and genetics from Queen’s University and has recently completed his MSc from the University of Calgary in Epidemiology focusing on risk prediction for cancer screening and prediction. He is relatively new to the world of real-world evidence (RWE) and hopes to branch out into health outcomes research during his PhD. Finally, as a cancer survivor he hopes to bring a patient perspective to cancer research using RWE.

Mr. Robert Basmadijan

Mr. Robert Basmadjian

PhD Student

Mr. Robert Basmadjian is a PhD student at the University of Calgary. His research specializes in breast cancer precision medicine in young women, including the development of outcome prediction models and genomic epidemiology.

Dr. Ofodile Joe-Uzuegbu

Dr. Ofodile Joe-Uzuegbu

Senior Research Assistant

Dr. Ofodile Joe-Uzuegbu is a senior research assistant and an international medical graduate, who is currently in the Precision Health Program at the University of Calgary, specializing in Quality and Safety Leadership. He is also a member of the Tarrant Viral Watch Team, Department of Family Medicine, University of Calgary.

Dr. Huma Shakir

Dr. Huma Shakir

Senior Research Assistant

Dr. Huma Shakir is an international medical graduate with over 5 years of experience in Internal Medicine. She worked as a Registrar of Internal Medicine in Pakistan and was a team leader and fundraiser for Insulin Bank in 2014, that provided free insulin to low-income diabetic patients. Currently she is working as a Research Assistant – Oncology with University of Calgary and pursing a certification in Applied Clinical Research from McMaster University, Ontario. Huma has worked as a Covid-19 Contact Tracing Specialist with Alberta Health Services and is an active advisory committee member for a community-based research project at University of Alberta that describes the aging experiences of older immigrant women in Alberta. She also worked at various medical clinics in Red Deer and Edmonton as a patient care coordinator and clinical assistant. She was a part of a team of doctors, working as a physician under supervision, providing healthcare to geriatric patients at Good Samaritan Clinic and Glenrose Rehabilitation Hospital in Edmonton, AB.

ding (002)

Mr. Philip Ding

Senior Research Assistant

Mr. Philip Ding is a medical student at the University of Alberta. He recently completed his undergraduate studies in Molecular Genetics and Global Health at the University of Toronto, where he conducted oncology research that spanned from liquid biopsies to palliative care. Philip currently serves as a research analyst in the Oncology Outcomes group, providing statistical support and leading projects centred around cancer health services.

Core Analysts

Dr. Yuan Xu (PhD), Ms. Kristine Kong (MSc), Ms. Tasnima Abedin (MSc)

Qualitative Lead

Dr. Colleen Cuthbert (PhD)

Ad Hoc Team

Data abstractors (medical chart reviews)

Patient Advisors

Ms. Cathie Hays, Mr. Barry Stein

Our vision is to lead in oncology through a forward-thinking, fit-for-purpose, real-world evidence approach that incorporates enriched data sources and advanced analytics.